- Home
- AVB vs IDXX Comparison
AVB vs IDXX Comparison
Compare AVB & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVB
- IDXX
- Stock Information
- Founded
- AVB 1978
- IDXX 1983
- Country
- AVB United States
- IDXX United States
- Employees
- AVB N/A
- IDXX 11000
- Industry
- AVB Real Estate Investment Trusts
- IDXX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AVB Real Estate
- IDXX Health Care
- Exchange
- AVB Nasdaq
- IDXX Nasdaq
- Market Cap
- AVB 29.5B
- IDXX 37.9B
- IPO Year
- AVB 1994
- IDXX 1991
- Fundamental
- Price
- AVB $204.58
- IDXX $489.39
- Analyst Decision
- AVB Buy
- IDXX Buy
- Analyst Count
- AVB 14
- IDXX 8
- Target Price
- AVB $237.43
- IDXX $524.75
- AVG Volume (30 Days)
- AVB 859.4K
- IDXX 998.2K
- Earning Date
- AVB 04-30-2025
- IDXX 05-01-2025
- Dividend Yield
- AVB 3.41%
- IDXX N/A
- EPS Growth
- AVB 19.57
- IDXX 4.80
- EPS
- AVB 8.03
- IDXX 10.82
- Revenue
- AVB $2,998,359,000.00
- IDXX $3,931,836,000.00
- Revenue This Year
- AVB $3.43
- IDXX $7.76
- Revenue Next Year
- AVB $5.38
- IDXX $7.74
- P/E Ratio
- AVB $25.53
- IDXX $45.31
- Revenue Growth
- AVB 6.12
- IDXX 5.56
- 52 Week Low
- AVB $180.40
- IDXX $356.14
- 52 Week High
- AVB $239.29
- IDXX $548.88
- Technical
- Relative Strength Index (RSI)
- AVB 46.59
- IDXX 72.89
- Support Level
- AVB $206.98
- IDXX $465.00
- Resistance Level
- AVB $209.67
- IDXX $495.56
- Average True Range (ATR)
- AVB 3.68
- IDXX 13.53
- MACD
- AVB 0.22
- IDXX 6.63
- Stochastic Oscillator
- AVB 8.37
- IDXX 93.78
About AVB AvalonBay Communities Inc.
AvalonBay Communities owns a portfolio of 289 apartment communities with over 87,000 units and is developing 17 additional properties with over 6,000 units. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington, D.C., California, and the Pacific Northwest.
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.